Distinct Signatures of Tumor-Associated Microbiota and Metabolome in Low-Grade vs. High-Grade Dysplastic Colon Polyps: Inference of Their Role in Tumor Initiation and Progression
暂无分享,去创建一个
Edoardo Pasolli | D. Ferrante | I. Dianzani | A. Aspesi | E. Robotti | P. Occhipinti | M. Manfredi | E. Barberis | R. Boldorini | B. Azzimonti | Marika Sculco | M. Mellai | Marta La Vecchia | M. G. Clavenna | Giulia Borgonovi | Elia Amede | Elisa Bona | Soni Joseph | Silvia Brossa
[1] Jianping Wang,et al. Gut flora profiling and fecal metabolite composition of colorectal cancer patients and healthy individuals , 2022, Experimental and therapeutic medicine.
[2] F. Mignone,et al. A Pilot Study on Clinical Scores, Immune Cell Modulation, and Microbiota Composition in Allergic Patients with Rhinitis and Asthma Treated with a Probiotic Preparation , 2021, International Archives of Allergy and Immunology.
[3] G. Garrity,et al. Valid publication of the names of forty-two phyla of prokaryotes. , 2021, International journal of systematic and evolutionary microbiology.
[4] I. Dianzani,et al. A new method for investigating microbiota-produced small molecules in adenomatous polyps. , 2021, Analytica chimica acta.
[5] Yan-lai Sun,et al. Integrated analysis of the faecal metagenome and serum metabolome reveals the role of gut microbiome-associated metabolites in the detection of colorectal cancer and adenoma , 2021, Gut.
[6] Lauren C. Dedecker,et al. Distinct colon mucosa microbiomes associated with tubular adenomas and serrated polyps , 2021, npj Biofilms and Microbiomes.
[7] F. Mignone,et al. Climatic Zone and Soil Properties Determine the Biodiversity of the Soil Bacterial Communities Associated to Native Plants from Desert Areas of North-Central Algeria , 2021, Microorganisms.
[8] G. Gkoutos,et al. Integration of the Microbiome, Metabolome and Transcriptomics Data Identified Novel Metabolic Pathway Regulation in Colorectal Cancer , 2021, International journal of molecular sciences.
[9] Xiaoya Zhao,et al. Serine Metabolism Regulates YAP Activity Through USP7 in Colon Cancer , 2021, Frontiers in Cell and Developmental Biology.
[10] Jun Yu,et al. Microbial Metabolites in Colorectal Cancer: Basic and Clinical Implications , 2021, Metabolites.
[11] A. Fodor,et al. On the robustness of inference of association with the gut microbiota in stool, swab and mucosal tissue samples , 2021, bioRxiv.
[12] A. Jemal,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.
[13] M. Pasca,et al. Gut Microbial Signatures in Sporadic and Hereditary Colorectal Cancer , 2021, International journal of molecular sciences.
[14] J. Qian,et al. Lactic acid promotes metastatic niche formation in bone metastasis of colorectal cancer , 2021, Cell communication and signaling : CCS.
[15] M. Avril,et al. “Driver-passenger” bacteria and their metabolites in the pathogenesis of colorectal cancer , 2021, Gut microbes.
[16] K. Clément,et al. Gut microbiota-derived metabolites as central regulators in metabolic disorders , 2020, Gut.
[17] Chunze Zhang,et al. Analyses of Potential Driver and Passenger Bacteria in Human Colorectal Cancer , 2020, Cancer management and research.
[18] P. Solanki,et al. Omics technologies for improved diagnosis and treatment of colorectal cancer: Technical advancement and major perspectives. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[19] C. Simó,et al. Dietary bioactive ingredients to modulate the gut microbiota-derived metabolite TMAO. New opportunities for functional food development. , 2020, Food & function.
[20] Gavin M Douglas,et al. PICRUSt2 for prediction of metagenome functions , 2020, Nature Biotechnology.
[21] Subbaya Subramanian,et al. Mucosal Microbiota and Metabolome along the Intestinal Tract Reveal a Location-Specific Relationship , 2020, mSystems.
[22] E. Giannoulatou,et al. Multi-omic profiling reveals associations between the gut mucosal microbiome, the metabolome, and host DNA methylation associated gene expression in patients with colorectal cancer , 2020, BMC Microbiology.
[23] M. Huynen,et al. Metabolic models predict bacterial passengers in colorectal cancer , 2020, Cancer & Metabolism.
[24] J. Cubiella,et al. Integrative Analysis of Fecal Metagenomics and Metabolomics in Colorectal Cancer , 2020, Cancers.
[25] Jun Sun,et al. Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer. , 2020, Gastroenterology.
[26] N. Segata,et al. Endogenous murine microbiota member Faecalibaculum rodentium and its human homolog protect from intestinal tumor growth , 2019, Nature Microbiology.
[27] Tomoyoshi Soga,et al. Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer , 2019, Nature Medicine.
[28] M. Hattori,et al. Effects of bowel preparation on the human gut microbiome and metabolome , 2019, Scientific Reports.
[29] F. Zhou,et al. Prognostic Significance of Serum Lactic Acid, Lactate Dehydrogenase, and Albumin Levels in Patients with Metastatic Colorectal Cancer , 2018, BioMed research international.
[30] M. Orešič,et al. Gut metabolome meets microbiome: A methodological perspective to understand the relationship between host and microbe. , 2018, Methods.
[31] S. Ogino,et al. Dysbiosis of the gut microbiota and colorectal cancer: the key target of molecular pathological epidemiology. , 2018, Journal of laboratory and precision medicine.
[32] Qiao Liu,et al. STAMP , 2018, Proceedings of the 24th ACM SIGKDD International Conference on Knowledge Discovery & Data Mining.
[33] S. Rampelli,et al. Shifts of Faecal Microbiota During Sporadic Colorectal Carcinogenesis , 2018, Scientific Reports.
[34] D. Pardoll,et al. Bacteroides fragilis Toxin Coordinates a Pro-carcinogenic Inflammatory Cascade via Targeting of Colonic Epithelial Cells. , 2018, Cell host & microbe.
[35] S. Madhunapantula,et al. Naturally occurring benzoic acid derivatives retard cancer cell growth by inhibiting histone deacetylases (HDAC) , 2017, Cancer biology & therapy.
[36] P. Rossing,et al. Trimethylamine N-oxide (TMAO) as a New Potential Therapeutic Target for Insulin Resistance and Cancer. , 2017, Current pharmaceutical design.
[37] Kathryn E. Hamilton,et al. Inflammation and Colorectal Cancer , 2017, Current Colorectal Cancer Reports.
[38] H. Qin,et al. Mucosa-associated microbiota signature in colorectal cancer , 2017, European Journal of Clinical Microbiology & Infectious Diseases.
[39] Xiaodong Li,et al. Elevated Circulating Trimethylamine N-Oxide Levels Contribute to Endothelial Dysfunction in Aged Rats through Vascular Inflammation and Oxidative Stress , 2017, Front. Physiol..
[40] Jasmine Chong,et al. MicrobiomeAnalyst: a web-based tool for comprehensive statistical, visual and meta-analysis of microbiome data , 2017, Nucleic Acids Res..
[41] Ashish K. Tiwari,et al. Metabolic reprogramming of the premalignant colonic mucosa is an early event in carcinogenesis , 2017, Oncotarget.
[42] Niklaus J. Grünwald,et al. Metacoder: An R package for visualization and manipulation of community taxonomic diversity data , 2016, bioRxiv.
[43] Elizabeth P. Ryan,et al. Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool , 2016, Cancer & metabolism.
[44] Jun Sun,et al. Gut microbiota, inflammation and colorectal cancer , 2016, Genes & diseases.
[45] J. Goedert,et al. Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations , 2016, PloS one.
[46] L. Bravo,et al. Different gastric microbiota compositions in two human populations with high and low gastric cancer risk in Colombia , 2016, Scientific Reports.
[47] S. Mazmanian,et al. Gut biogeography of the bacterial microbiota , 2015, Nature Reviews Microbiology.
[48] R. Sartor,et al. High throughput sequencing reveals distinct microbial populations within the mucosal and luminal niches in healthy individuals , 2015, Gut microbes.
[49] P. Loke,et al. Inferred metagenomic comparison of mucosal and fecal microbiota from individuals undergoing routine screening colonoscopy reveals similar differences observed during active inflammation , 2015, Gut microbes.
[50] Robert G. Beiko,et al. STAMP: statistical analysis of taxonomic and functional profiles , 2014, Bioinform..
[51] Harry J. Flint,et al. The gut microbiota, bacterial metabolites and colorectal cancer , 2014, Nature Reviews Microbiology.
[52] J. Goedert,et al. Fecal metabolomics: assay performance and association with colorectal cancer. , 2014, Carcinogenesis.
[53] G. Xie,et al. Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery. , 2014, Journal of proteome research.
[54] Bangmao Wang,et al. The secondary bile acid, deoxycholate accelerates intestinal adenoma–adenocarcinoma sequence in Apcmin/+ mice through enhancing Wnt signaling , 2014, Familial Cancer.
[55] Bangmao Wang,et al. The secondary bile acid, deoxycholate accelerates intestinal adenoma–adenocarcinoma sequence in Apcmin/+ mice through enhancing Wnt signaling , 2014, Familial Cancer.
[56] E. Riboli,et al. Plasma methionine, choline, betaine, and dimethylglycine in relation to colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.
[57] C. Hassan,et al. Systematic review with meta‐analysis: the incidence of advanced neoplasia after polypectomy in patients with and without low‐risk adenomas , 2014, Alimentary pharmacology & therapeutics.
[58] M. Ebert,et al. Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome , 2014, European Journal of Clinical Microbiology & Infectious Diseases.
[59] James R. Cole,et al. Ribosomal Database Project: data and tools for high throughput rRNA analysis , 2013, Nucleic Acids Res..
[60] M. Meyerson,et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. , 2013, Cell host & microbe.
[61] Amy M. Sheflin,et al. Stool Microbiome and Metabolome Differences between Colorectal Cancer Patients and Healthy Adults , 2013, PloS one.
[62] Florian Grimpen,et al. Impact of Colonoscopy Bowel Preparation on Intestinal Microbiota , 2013, PloS one.
[63] Susan Holmes,et al. phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data , 2013, PloS one.
[64] T. Wiele,et al. Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model , 2012, The ISME Journal.
[65] Bas E Dutilh,et al. A bacterial driver–passenger model for colorectal cancer: beyond the usual suspects , 2012, Nature Reviews Microbiology.
[66] M. Zheng,et al. Distinct urinary metabolic profile of human colorectal cancer. , 2012, Journal of proteome research.
[67] Carmen Buchrieser,et al. Escherichia coli Induces DNA Double-Strand Breaks in Eukaryotic Cells , 2006, Science.
[68] E. Purdom,et al. Diversity of the Human Intestinal Microbial Flora , 2005, Science.
[69] Cynthia L. Sears,et al. Bacteroides fragilis Enterotoxin Induces Intestinal Epithelial Cell Secretion of Interleukin-8 through Mitogen-Activated Protein Kinases and a Tyrosine Kinase-Regulated Nuclear Factor-κB Pathway , 2004, Infection and Immunity.
[70] N E Day,et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection , 2002, Public Health Nutrition.
[71] P. Green,et al. Base-calling of automated sequencer traces using phred. I. Accuracy assessment. , 1998, Genome research.
[72] D. Pardoll,et al. Bacteroides fragilis Toxin Coordinates a Pro-carcinogenic Inflammatory Cascade via Targeting of Colonic Epithelial Cells. , 2018, Cell host & microbe.
[73] A. Kane,et al. Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection. , 2015, The Journal of infectious diseases.
[74] C M Payne,et al. Deoxycholate induces mitochondrial oxidative stress and activates NF-kappaB through multiple mechanisms in HCT-116 colon epithelial cells. , 2007, Carcinogenesis.